A Tel Aviv University study found that a drug that was designated as an “orphan drug” by the FDA – meaning it is used to treat rare diseases and is subject to separate regulations – can also treat a variety of symptoms associated with autism, intellectual disabilities, and Alzheimer’s disease. “This study is an important milestone on the way to developing a drug, or drugs, that will help children with autism stemming from genetic mutations, as well as Alzheimer’s patients,” Grozes concluded. Read the full article on the Israel Trade and Economic Commission's Website: https://israeltrade.org.au/2021/12/09/drug-for-rare-disease-effective-for-alzheimers-autism-treatment/